Sectoral Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Sectoral Asset Management’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-81,500	Closed	-$603K	–	93
2024 Q4	$603K	Buy	+81,500	New	+$755K	0.4%	49
2024 Q1	–	Sell	-198,800	Closed	-$1.62M	–	101
2023 Q4	$1.62M	Sell	198,800 -786,200	-80%	-$4.11M	0.7%	58
2023 Q3	$4.48M	Buy	+985,000	New	+$6.43M	0.87%	49
2022 Q2	–	Sell	-222,000	Closed	-$3.7M	–	118
2022 Q1	$3.7M	Buy	+222,000	New	+$3.43M	0.66%	58
2020 Q3	–	Sell	-20,800	Closed	-$571K	–	136
2020 Q2	$571K	Buy	+20,800	New	+$684K	0.05%	126
2018 Q4	–	Sell	-12,957	Closed	-$146K	–	119
2018 Q3	$146K	Buy	+12,957	New	+$184K	0.02%	149

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Sectoral Asset Management's IOVA Position: Q1 2025 in Review

Sectoral Asset Management sold out of Iovance Biotherapeutics (IOVA) in Q1 2025, closing a stake of 81,500 shares — an estimated $603K sold.

Sectoral Asset Management first reported a position in IOVA in Q3 2018 and held it in 6 quarters. The position peaked at $4.48M in Q3 2023. 302 funds tracked by Wall St. Rank hold IOVA as of Q1 2025.

Sectoral Asset Management reported no remaining Iovance Biotherapeutics position as of Q1 2025 after selling out during the quarter.
Sectoral Asset Management sold 81,500 Iovance Biotherapeutics shares in Q1 2025, an estimated $603K.
Sectoral Asset Management first reported a position in Iovance Biotherapeutics in Q3 2018 and held it in 6 quarters.
Sectoral Asset Management's Iovance Biotherapeutics position peaked at $4.48M in Q3 2023.
302 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2025.

Based on Sectoral Asset Management's 13F filing for Q1 2025, filed 15 May 2025.